Synthes and Lilly Sign Development and Collaboration Agreement
- Details
- Category: Eli Lilly and Company
![Lilly Lilly](/images/stories/logo/lilly.gif)
GlaxoSmithKline and Valeant announce US FDA approval of Potiga™ (ezogabine)
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/stories/logo/gsk.gif)
Abbott Reports Interim Results From Phase III Open-Label Study of Investigational Treatment for Advanced Parkinson's Disease
- Details
- Category: Abbott
![Abbott Abbott](/images/stories/logo/abbott.gif)
Millions of children in the world's poorest countries could receive vaccination against rotavirus diarrhoeal disease
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/stories/logo/gsk.gif)
Pfizer Conducts First "Virtual" Clinical Trial Allowing Patients to Participate Regardless of Geography
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/stories/logo/pfizer_b.gif)
Novartis drug Glivec® shows significant overall survival benefit
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
Pfizer and Hisun Sign MOU to Establish a Joint Venture
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/stories/logo/pfizer_b.gif)
More Pharma News ...
- Bristol-Myers Squibb and Roche Enter into a Clinical Collaboration Agreement
- Novartis highlights extensive data on numerous compounds at ASCO
- AstraZeneca and Heptares collaborate to investigate important GPCR drug targets
- Sanofi and DNDi - Drugs for Neglected Diseases initiative - Sign an Innovative Agreement
- RoACTEMRA could change the current standard of treatment for people living with rheumatoid arthritis
- Pfizer Announces New Strategic Partnerships with ICON and PAREXEL International Corporation
- Major Subgroup Analysis Shows Bayer's Rivaroxaban is Highly Effective in the Prevention of Recurrent Strokes